OX-LDL up-regulates the vascular endothelial growth factor-to-pigment epithelium-derived factor ratio in human retinal pigment epithelial cells

Current Eye Research

Volumn 36, Issue 4, 2011, Pages 379-385

  Yin, Lili ^a   Wu, Xingwei ^a   Gong, Yuanyuan ^a   Shi, Yuhua ^a   Qiu, Yating ^a   Zhang, Hongmei ^a   Liu, Xiaojuan ^a   Gu, Qing ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Age related macular degeneration; Mitogen activated protein kinases; Oxidized low density lipoprotein; Pigment epithelium derived factor; Retinal pigment epithelial cells; Vascular endothelial growth factor

Indexed keywords

LOW DENSITY LIPOPROTEIN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE P38; OXIDIZED LOW DENSITY LIPOPROTEIN; PIGMENT EPITHELIUM DERIVED FACTOR; STRESS ACTIVATED PROTEIN KINASE; VASCULOTROPIN;

APOPTOSIS; ARTICLE; CELL PROLIFERATION; CELL STRUCTURE; CELL VIABILITY; ENZYME INHIBITION; EPITHELIUM CELL; HUMAN; HUMAN CELL; NICK END LABELING; PIGMENT EPITHELIUM; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; UPREGULATION; WESTERN BLOTTING;

APOPTOSIS; BLOTTING, WESTERN; CELL LINE; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; EYE PROTEINS; FLOW CYTOMETRY; HUMANS; IN SITU NICK-END LABELING; LIPOPROTEINS, LDL; MITOGEN-ACTIVATED PROTEIN KINASES; NERVE GROWTH FACTORS; RETINAL PIGMENT EPITHELIUM; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SERPINS; UP-REGULATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 79952740871     PISSN: 02713683     EISSN: 14602202     Source Type: Journal    
DOI: 10.3109/02713683.2010.537427     Document Type: Article

References (54)

1. Pascolini D, Mariotti SP, Pokharel GP, et al. 2002 global update of available data on visual impairment: A compilation of population-based prevalence studies. Ophthalmic Epidemiol. 2004;11:67-115. (Pubitemid 38530465)
2. Congdon N, O'Colmain B, Klaver CC, et al. Causes and prevalence of visual impairment among adults in the United States. Arch Ophthalmol. 2004;122:477-485. (Pubitemid 38456282)
3. de Jong PT. Age-related macular degeneration. N Engl J Med. 2006;355:1474-1485.
4. Robman L, McNeil J, Dimitrov P, et al. Methodology of the Cardiovascular Health and Age-Related Maculopathy (CHARM) Study. Ophthalmic Epidemiol. 2004;11:161-179. (Pubitemid 39369427)
5. Vingerling JR, Dielemans I, Bots ML, et al. Age-related macular degeneration is associated with atherosclerosis: The Rotterdam Study. Am J Epidemiol. 1995;142:404-409.
6. Mitchell P, Smith W, Attebo K, et al. Prevalence of age-related maculopathy in Australia. Ophthalmology. 1995;102:1450-1460.
7. Klein R, Klein BE, Linton KL. Prevalence of age-related maculopathy. Ophthalmology. 1992;99:933-943.
8. VanNewkirk MR, Nanjan MB, Wanh JJ. The prevalence of age-related maculopathy: The visual impairment project. Ophthalmology. 2000;107:1593-1600.
9. Mitchell P, Wang JJ, Smith W, et al. Smoking and the 5-year incidence of age-related maculopathy: The Blue Mountains Eye study. Arch Ophthalmol. 2002;120:1357-1363. (Pubitemid 36105441)
10. Thornton J, Edwards R, Mitchell P, et al. Smoking and age-related macular degeneration: A review of association. Eye. 2005;19:935-944. (Pubitemid 43114972)
11. Klein R, Klein BE, Tomany SC, et al. The association of cardiovascular disease with the long-term incidence of agerelated maculopathy. Ophthalmology. 2003;110:1273-1280.
12. Fraser-Bell S, Wu J, Klein R, et al. Cardiovascular risk factors and age-related macular degeneration: The Los Angeles Latino Eye Study. Am J Ophthalmol. 2008;145:308-316.
13. Hogg RE, Woodside JV, Gilchrist SE, et al. Cardiovascular disease and hypertension are strong risk factors for choroidal neovascularization. Ophthalmology. 2008;115:1046-1052.
14. Guymer RH, Chiu AW, Lim L, et al. HMG CoA reductase inhibitors (statins): Do they have a role in age-related macular degeneration? Surv Ophthalmol. 2005;50:194-206. (Pubitemid 40340950)
15. Mares-Perlman JA, Brady WE, Klein R, et al. Dietary fat and age-related maculopathy. Arch Ophthalmol. 1995;113:743-748.
16. Tan JS, Mitchell P, Smith W, et al. Cardiovascular risk factors and the long-term incidence of age-related macular degeneration: The Blue Mountain Eye Study. Ophthalmology. 2007;114:1143-1150. (Pubitemid 46829381)
17. Huang JD, Presley JB, Chimento MF, et al. Age-related changes in human macular Bruch's membrane as seen by quick-freeze/deep-etch. Exp Eye Res. 2007;85:202-218. (Pubitemid 47087796)
18. Takahashi Y, Zhu H, Yoshimoto T. Essential roles of lipoxygenases in LDL oxidation and development of atherosclerosis. Antioxid Redox Signal. 2005;7:425-431. (Pubitemid 40279810)
19. Rahaman SO, Lennon DJ, Febbraio M, et al. A CD36- dependent signaling cascade is necessary for macrophage foam cell formation. Cell Metab. 2006;4:211-221. (Pubitemid 44283954)
20. Hayes KC, Lindsey S, Stephan ZF, et al. Retinal pigment epithelium possesses both LDL and scavenger receptor activity. Invest Ophthalmol Vis Sci. 1989;30:225-232. (Pubitemid 19055599)
21. Ryeom SW, Silverstein RL, Scotto A, et al. Binding of anionic phospholipids to retinal pigment epithelium may be mediated by the scavenger receptor CD36. J Biol Chem. 1996;271:20536-20539. (Pubitemid 26281828)
22. Gordiyenko N, Campos M, Lee JW, et al. RPE cells internalize low-density lipoprotein (LDL) and oxidized LDL (oxLDL) in large quantities in vitro and in vivo. Invest Ophthalmol Vis Sci. 2004;45:2822-2829. (Pubitemid 38998882)
23. Yu AL, Lorenz RL, Haritoglou C, et al. Biological effects of native and oxidized low-density lipoproteins in cultured human retinal pigment epithelial cells. Exp Eye Res. 2009;88:495-503.
24. Ramos MA, Kuzuya M, Esaki T, et al. Induction of macrophage VEGF in response to oxidized LDL and VEGF accumulation in human atherosclerotic lesions. Arterioscler Thromb Vasc Biol. 1998;18:1188-1196. (Pubitemid 28323605)
25. Duh EJ, Yang HS, Haller JA, et al. Vitreous levels of pigment epithelium-derived factor and vascular endothelial growth factor: Implications for ocular angiogenesis. Am J Ophthalmol. 2004;137:668-674. (Pubitemid 38446681)
26. Holekamp NM, Bouck N, Volpert O. Pigment epithelium-derived factor is deficient in the vitreous of patients with choroidal neovascularization due to age-related macular degeneration. Am J Ophthalmol. 2002;134:220-227. (Pubitemid 34831826)
27. Rubic T, Lorenz RL. Downregulated CD36 and oxLDL uptake and stimulated ABCA1/G1 and cholesterol efflux as anti-atherosclerotic mechanisms of interleukin-10. Cardiovasc Res. 2006;69:527-535. (Pubitemid 43098809)
28. Mironova M, Virella G, Lopes-Virella MF. Isolation and characterization of human antioxidized LDL autoantibodies. Arterioscler Thromb Vasc Biol. 1996;16:222-229. (Pubitemid 26056240)
29. Curcio CA, Millican CL, Bailey T, et al. Accumulation of cholesterol with age in human Bruch's membrane. Invest Ophthalmol Vis Sci. 2001;42:265-274. (Pubitemid 32059440)
30. Yang P, Peairs JJ, Tano R, et al. Caspase-8-mediated apoptosis in human RPE cells. Invest Ophthalmol Vis Sci. 2007;48:3341-3349. (Pubitemid 351261182)
31. Fliesler SJ, Florman R, Rapp LM, et al. In vivo biosynthesis of cholesterol in the rat retina. FEBS Lett. 1993;335:234-238. (Pubitemid 23350413)
32. Fliesler SJ, Richards MJ, Miller CY, et al. Cholesterol synthesis in the vertebrate retina: Effects of U18666A on rat retinal structure, photoreceptor membrane assembly, and sterol metabolism and composition. Lipids. 2000;35:289-296. (Pubitemid 30198774)
33. Yamada Y, Tian J, Yang Y, et al. Oxidized low density lipoproteins induce a pathologic response by retinal pigmented epithelial cells. J Neurochem. 2008;105:1187-1197. (Pubitemid 351590780)
34. Cominacini L, Rigoni A, Pasini AF, et al. The binding of oxidized low density lipoprotein (ox-LDL) to ox-LDL receptor-1 reduces the intracellular concentration of nitric oxide in endothelial cells through an increased production of superoxide. J Biol Chem. 2001;276:13750-13755.
35. Hoppe G, Marmorstein AD, Pennock EA, et al. Oxidized low density lipoprotein-induced inhibition of processing of photoreceptor outer segments by RPE. Invest Ophthalmol Vis Sci. 2001;42:2714-2720. (Pubitemid 32954884)
36. Moreira EF, Larrayoz IM, Lee JW, et al. 7-Ketocholesterol is present in lipid deposits in the primate retina: Potential implication in the induction of VEGF and CNV formation. Invest Ophthalmol Vis Sci. 2009;50:523-532.
37. Pierce EA, Avery RL, Foley ED, et al . Vascular endothelial growth factor/vascular permeability factor expression in a mouse model of retinal neovascularization. Proc Natl Acad Sci. 1995;92(3):905-909.
38. Dawson DW, Volpert OV, Gillis P, et al. Pigment epitheliumderived factor: A potent inhibitor of angiogenesis. Science. 1999;285:245-258.
39. Becerra SP. Focus on molecules: Pigment epithelium-derived factor (PEDF). Exp Eye Res. 2006;82:739-740.
40. Filleur S, Nelius T, de Riese W, et al. Characterization of PEDF: A multi-functional serpin family protein. J. Cell. Biochem. 2009;106:769-775.
41. Bouck N. PEDF: Anti-angiogenic guardian of ocular function. Trends Mol Med. 2002;8:330-334. (Pubitemid 34733386)
42. Becerra SP. Structure-function studies on PEDF. A non-inhibitory serpin with neurotrophic activity. Adv Exp Med Biol. 1997;425:223-237. (Pubitemid 28035786)
43. Smith CP, Steinle JJ. Changes in growth factor expression in normal aging of the rat retina. Exp Eye Res. 2007;85:817-824. (Pubitemid 350166368)
44. Ohno-Matsui K, Morita I, Tombran-Tink J. Novel mechanism for age-related macular degeneration: An equilibrium shift between the angiogenesis factors VEGF and PEDF. J Cell Physiol;. 2001;189:323-333. (Pubitemid 33063300)
45. Salomonsson L, Pettersson S, Englund MC, et al. Posttranscriptional regulation of VEGF expression by oxidised LDL in human macrophages. Eur J Clin Invest. 2002;32:767-774. (Pubitemid 35334973)
46. Inoue M, Itoh H, Tanaka T, et al. Oxidized LDL regulates vascular endothelial growth factor expression in human macrophages and endothelial cells through activation of peroxisome proliferator-activated receptor-gamma. Arterioscler Thromb Vasc Biol. 2001;21:560-566. (Pubitemid 32323389)
47. Pignolo RJ, Francis MK, Rotenberg MO, et al. Putative role for EPC-1/PEDF in the G0 growth arrest of human diploid fibroblasts. J Cell Physiol. 2003;195:12-20. (Pubitemid 36292755)
48. Lopez PF, Sippy BD, Lambert HM, et al. Transdifferentiated retinal pigment epithelial cells are immunoreactive for vascular endothelial growth factor in surgically excised age-related macular degeneration-related choroidal neovascular membranes. Invest Ophthalmol Vis Sci. 1996;37:855-868.
49. Armstrong D, Ueda T, Ueda T, et al. Lipid hydroperoxide stimulates retinal neovascularization in rabbit retina through expression of tumor necrosis factor-alpha, vascular endothelial growth factor and platelet-derived growth factor. Angiogenesis. 1998;2:93-104. (Pubitemid 128511976)
50. Tamai K, Spaide RF, Ellis EA, et al. Lipid hydroperoxide stimulates subretinal choroidal neovascularization in the rabbit. Exp Eye Res. 2002;74:301-308. (Pubitemid 34948405)
51. Riazy M, Chen JH, Steinbrecher UP. VEGF secretion by macrophages is stimulated by lipid and protein components of OxLDL via PI3-kinase and PKCζ activation and is independent of OxLDL uptake. Atherosclerosis. 2009;204:47-54.
52. Josko J, Mazurek M. Transcription factors having impact on VEGF gene expression in angiogenesis. Med Sci Monit. 2004;10:RA89-RA98.
53. Klettner A, Graefes JR. Constitutive and oxidative-stress-induced expression of VEGF in the RPE are differently regulated by different mitogen-activated protein kinases. Graefes Arch Clin Exp Ophthalmol. 2009;247:1487-1492.
54. Dandapat A, Hu C, Sun L, et al. Small concentrations of oxLDL induce capillary tube formation from endothelial cells via LOX-1-dependent redox-sensitive pathway. Arterioscler Thromb Vasc Biol. 2007;27:2435-2442. (Pubitemid 350203961)